Inventor · disambiguated record
Michael J. Roberts
Also filed as: ROBERTS MICHAEL · ROBERTS MICHAEL J · ROBERTS MICHAEL JAMES · ROBERTS MICHAEL S
32 granted patents·26 pending applications·794 citations·filing 2000–2019
97Inventor score
Files withCHELSEA THERAPEUTICS INC13NEKTAR THERAPEUTICS8ROBERTS MICHAEL J6NEKTAR THERAPEUTICS AL CORP5SHEARWATER CORP4
Top patents by PatentIndex Score
58 records- 0198USD499397SHeadsetLOGITECH EUROP SA·Filed 2004·Granted Dec 7, 2004·153 cites·1 claims
- 0298US6436386B1Hydroxyapatite-targeting poly (ethylene glycol) and related polymersSHEARWATER CORP·Filed 2000·Granted Aug 20, 2002·244 cites·80 claims
- 0396US7662365B2Polymer conjugates of opioid antagonistsNEKTAR THERAPEUTICS·Filed 2006·Granted Feb 16, 2010·36 cites·22 claims
- 0495US7056500B2Polymer conjugates of opioid antagonistsNEKTAR THERAPEUTICS AL CORP·Filed 2002·Granted Jun 6, 2006·58 cites·19 claims
- 0595US6908963B2Thioester polymer derivatives and method of modifying the N-terminus of a polypeptide therewithNEKTAR THERAPEUTICS AL CORP·Filed 2001·Granted Jun 21, 2005·39 cites·32 claims
- 0694US7511095B2Thioester-terminated water soluble polymers and method of modifying the N-terminus of a polypeptide therewithNEKTAR THERAPEUTICS AL CORP·Filed 2006·Granted Mar 31, 2009·12 cites·19 claims
- 0794US7078496B2Thioester-terminated water soluble polymers and method of modifying the N-terminus of a polypeptide therewithNEKTAR THERAPEUTICS AL CORP·Filed 2002·Granted Jul 18, 2006·36 cites·43 claims
- 0893US6638500B1Polyol-IFN-βconjugates modified at Cys-17 and composition containing sameAPPLIED RESEARCH SYSTEMS·Filed 2000·Granted Oct 28, 2003·79 cites·5 claims
- 0992US8008285B2Droxidopa and pharmaceutical composition thereof for the treatment of fibromyalgiaCHELSEA THERAPEUTICS INC·Filed 2008·Granted Aug 30, 2011·28 cites·20 claims
- 1092US7834088B2Thioester-terminated water soluble polymers and method of modifying the N-terminus of a polypeptide therewithNEKTAR THERAPEUTICS·Filed 2009·Granted Nov 16, 2010·11 cites·20 claims
- 1190US8329876B2Thioester-terminated water soluble polymers and method of modifying the N-terminus of a polypeptide therewithROBERTS MICHAEL J·Filed 2011·Granted Dec 11, 2012·6 cites·17 claims
- 1289US8071678B2Thioester-terminated water soluble polymers and method of modifying the N-terminus of a polypeptide therewithROBERTS MICHAEL J·Filed 2010·Granted Dec 6, 2011·6 cites·15 claims
- 1388US8617530B2Polymer conjugates of opioid antagonistsNEKTAR THERAPEUTICS·Filed 2012·Granted Dec 31, 2013·8 cites·12 claims
- 1488US8349307B2Polymer conjugates of opioid antagonistsNEKTAR THERAPEUTICS·Filed 2009·Granted Jan 8, 2013·7 cites·4 claims
- 1586US8383681B2Droxidopa and pharmaceutical composition thereof for the treatment of mood disorders, sleep disorders or attention deficit disordersCHELSEA THERAPEUTICS INC·Filed 2008·Granted Feb 26, 2013·8 cites·10 claims
- 1685US7829708B2Metabolically inert antifolates for treating disorders of abnormal cellular proliferation and inflammationCHELSEA THERAPEUTICS INC·Filed 2005·Granted Nov 9, 2010·9 cites·15 claims
- 1783US8372422B2Hydroxyapatite-targeting poly(ethylene glycol) and related polymersNEKTAR THERAPEUTICS·Filed 2010·Granted Feb 12, 2013·2 cites·17 claims
- 1882US7267941B2Cyanovirin variant-polymer conjugatesNEKTAR THERAPEUTICS AL·Filed 2003·Granted Sep 11, 2007·20 cites·45 claims
- 1981US10098401B2Augmented reality motorcycle helmetNEW SKULLY INC·Filed 2015·Granted Oct 16, 2018·7 cites·4 claims
- 2077US8530653B2Enzyme inhibiting compoundsROBERTS MICHAEL J·Filed 2010·Granted Sep 10, 2013·4 cites·6 claims
- 2177US7829074B2Hydroxypatite-targeting poly(ethylene glycol) and related polymersNEKTAR THERAPEUTICS·Filed 2001·Granted Nov 9, 2010·5 cites·20 claims
- 2275US7951812B2Substituted pyrrolo[2,3-d]pyrimidines as antifolatesCHELSEA THERAPEUTICS INC·Filed 2008·Granted May 31, 2011·2 cites·46 claims
- 2375US7700314B2Method for producing polyol-IFN-β conjugateMERCK SERONO SA·Filed 2007·Granted Apr 20, 2010·2 cites·7 claims
- 2471US7226937B2Methods for modulating phototoxicityREGENTS ON BEHALF OF THE UNIVE·Filed 2005·Granted Jun 5, 2007·1 cites·7 claims
- 2568US8784849B2Hydroxyapatite-targeting poly(ethylene glycol) and related polymersNEKTAR THERAPEUTICS·Filed 2013·Granted Jul 22, 2014·0 cites·13 claims
- 2667US6992071B2Methods for modulating phototoxicityREGENTS ON BEHALF OF THE UNIVE·Filed 2003·Granted Jan 31, 2006·3 cites·5 claims
- 2761US8658652B2Antifolate combinationsROBERTS MICHAEL J·Filed 2011·Granted Feb 25, 2014·1 cites·22 claims
- 2859US8440623B2Polymer stabilized neuropeptidesBENTLEY MICHAEL DAVID·Filed 2011·Granted May 14, 2013·0 cites·24 claims
- 2959US8008435B2Polymer stabilized neuropeptidesNEKTAR THERAPEUTICS·Filed 2003·Granted Aug 30, 2011·0 cites·20 claims
- 3058US7357925B2Method for treating disorders and diseases treatable with human fibroblast interferonSERONOSA LAB·Filed 2003·Granted Apr 15, 2008·1 cites·19 claims
- 3156US2003144207A1Polymer stabilized neuropeptidesSHEARWATER CORP·Filed 2003·Application pending·0 cites
- 3256US2009253720A1Antifolate compositionsCHELSEA THERAPEUTICS INC·Filed 2009·Application pending·0 cites
- 3356US2003139346A1Polymer stabilized neuropeptidesFiled 2003·Application pending·0 cites
- 3455US7547509B2Cyanovirin variant-polymer conjugatesNEKTAR THERAPEUTICS AL CORP·Filed 2007·Granted Jun 16, 2009·0 cites·10 claims
- 3555US2008227830A1Droxidopa and pharmaceutical composition thereof for the treatment of neurally mediated hypotensionCHELSEA THERAPEUTICS INC·Filed 2008·Application pending·0 cites
- 3654US2005042188A1Method for modulating phototoxicityFiled 2004·Application pending·0 cites
- 3753US2002019340A1Polymer stabilized neuropeptidesFiled 2001·Application pending·0 cites
- 3853US2008015181A1Pharmaceutical Compositions Comprising DroxidopaCHELSEA THERAPEUTICS INC·Filed 2007·Application pending·0 cites
- 3953US2013143868A1Droxidopa and pharmaceutical composition thereof for the treatment of mood disorders, sleep disorders, or attention deficit disordersCHELSEA THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 4053US2002013266A1Polymer stabilized neuropeptidesSHEARWATER CORP·Filed 2001·Application pending·0 cites
- 4151US2012010293A1Droxidopa and pharmaceutical composition thereof for the treatment of mood disorders, sleep disorders, or attention deficit disordersROBERTS MICHAEL J·Filed 2011·Application pending·0 cites
- 4250US2019045866A1Augmented reality motorcycle helmetNEW SKULLY INC·Filed 2018·Application pending·0 cites
- 4349US2010008977A1Liposomally encapsulated hybrid adenovirus-semliki forest virus (sfv) vectors carrying rnai constructs and therapeutic genes for use against cancer targets and other diseasesBOULIKAS PARTHENIOS·Filed 2007·Application pending·0 cites
- 4449US2021008209A1Combination therapy for ttr amyloidosisCORINO THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 4548US2011081338A1Metabolically inert antifolates for treating disorders of abnormal cellular proliferation and inflammationCHELSEA THERAPEUTICS INC·Filed 2010·Application pending·0 cites
- 4648US2003017504A1Antibodies specific for poly(ethylene glycol)SHEARWATER CORP·Filed 2002·Application pending·0 cites
- 4748US2011082149A1Metabolically inert antifolates for treating disorders of abnormal cellular proliferation and inflammationCHELSEA THERAPEUTICS INC·Filed 2010·Application pending·0 cites
- 4847USD510931SEar-clip for personal audio deviceLOGITECH EUROP SA·Filed 2004·Granted Oct 25, 2005·6 cites·1 claims
- 4947US2013116286A1Droxidopa and pharmaceutical composition thereof for the treatment of neurally mediated hypotensionCHELSEA THERAPEUTICS INC·Filed 2012·Application pending·0 cites
- 5045US2011259786A1Droxidopa and pharmaceutical composition thereof for the treatment of fibromyalgiaROBERTS MICHAEL J·Filed 2011·Application pending·0 cites
Showing the top 50 of 58 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Michael J. Roberts files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →